secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytek Biosciences, Inc. (CTKB)
CIK:        0001831915
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001193125-23-283662
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cytek Biosciences posts updated corporate presentation, no material new info disclosed
--------------------------------------------------------------------------------

- Filing references updated corporate presentation made available on company website.
- Presentation slide lists CEO Dr. Wenbin Jiang, CFO Patrik Jeanmonod, and IR Paul Goodson.
- No specific financial figures, guidance changes, or operational updates are provided in the filing or exhibit.
- The 8-K furnishes the presentation under Regulation FD; content not incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/0001193125-23-283662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/d614953d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-283662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer